急性缺血性卒中血管内再灌注治疗时间与临床实践结局的关联
该回顾性队列研究基于美国Get With The Guidelines-Stroke全国质量登记数据库2015年1月至2016年12月的前瞻性收集数据,纳入6756例发病至穿刺时间≤8小时的前循环大血管闭塞急性缺血性卒中并接受血管内再灌注治疗的患者。中位发病至穿刺时间230分钟,中位入院至穿刺时间87分钟,85.9%实现实质性再灌注,6.7%发生症状性颅内出血,19.6%院内死亡/临终关怀出院。在发病至穿刺30-270分钟时间窗内,每缩短15分钟与出院独立行走绝对增加1.14%、院内死亡/临终关怀出院绝对降低0.77%、症状性颅内出血绝对降低0.22%相关;入院至穿刺30-120分钟窗内每缩短15分钟与出院回家绝对增加2.13%、院内死亡/临终关怀出院绝对降低1.48%相关。
要点
- 发病至穿刺30-270分钟内,每缩短15分钟与出院独立行走绝对增加1.14%(95%CI 0.75%-1.53%)相关。
- 发病至穿刺30-270分钟内,每缩短15分钟与院内死亡/临终关怀出院绝对降低0.77%(95%CI -1.07%至-0.47%)相关。
- 入院至穿刺30-120分钟内,每缩短15分钟与出院回家绝对增加2.13%(95%CI 0.81%-3.44%)相关。
- 入院至穿刺30-120分钟内,每缩短15分钟与院内死亡/临终关怀出院绝对降低1.48%(95%CI -2.60%至-0.36%)相关。
- 症状性颅内出血发生率6.7%(449/6693),院内死亡/临终关怀出院19.6%(1326/6756)。
适用人群与场景
- 美国全国质量登记数据库中2015年1月至2016年12月的前循环大血管闭塞急性缺血性卒中患者,发病至穿刺时间≤8小时,接受血管内再灌注治疗。
研究设计与关键结果
- 回顾性队列研究,纳入6756例前循环大血管闭塞急性缺血性卒中患者,中位年龄69.5岁(SD 14.8),女性51.2%(3460/6756),基线NIHSS中位数17分(IQR 12-22)。
- 中位发病至穿刺时间230分钟(IQR 170-305),中位入院至穿刺时间87分钟(IQR 62-116),实质性再灌注(mTICI 2b-3)率85.9%(5433/6324)。
- 出院时独立行走36.9%(2132/5783),功能独立(mRS 0-2)23.0%(1225/5334)。
- 发病至穿刺时间与结局呈非线性关系,30-270分钟段斜率较271-480分钟段更陡。
- 发病至穿刺30-270分钟内每缩短15分钟:出院独立行走绝对增加1.14%(95%CI 0.75%-1.53%),院内死亡/临终关怀出院绝对降低0.77%(95%CI -1.07%至-0.47%),症状性颅内出血绝对降低0.22%(95%CI -0.40%至-0.03%)。
- 入院至穿刺30-120分钟内每缩短15分钟:出院回家绝对增加2.13%(95%CI 0.81%-3.44%),院内死亡/临终关怀出院绝对降低1.48%(95%CI -2.60%至-0.36%)。
证据类型、等级与局限
- 证据类型:回顾性队列研究,使用前瞻性收集的全国质量登记数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现支持努力缩短卒中患者到达医院及接受血管内治疗的时间。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Randomized clinical trials suggest benefit of endovascular-reperfusion therapy for large vessel occlusion in acute ischemic stroke (AIS) is time dependent, but the extent to which it influences outcome and generalizability to routine clinical practice remains uncertain.
OBJECTIVE: To characterize the association of speed of treatment with outcome among patients with AIS undergoing endovascular-reperfusion therapy.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study using data prospectively collected from January 2015 to December 2016 in the Get With The Guidelines-Stroke nationwide US quality registry, with final follow-up through April 15, 2017. Participants were 6756 patients with anterior circulation large vessel occlusion AIS treated with endovascular-reperfusion therapy with onset-to-puncture time of 8 hours or less.
EXPOSURES: Onset (last-known well time) to arterial puncture, and hospital arrival to arterial puncture (door-to-puncture time).
MAIN OUTCOMES AND MEASURES: Substantial reperfusion (modified Thrombolysis in Cerebral Infarction score 2b-3), ambulatory status, global disability (modified Rankin Scale [mRS]) and destination at discharge, symptomatic intracranial hemorrhage (sICH), and in-hospital mortality/hospice discharge.
RESULTS: Among 6756 patients, the mean (SD) age was 69.5 (14.8) years, 51.2% (3460/6756) were women, and median pretreatment score on the National Institutes of Health Stroke Scale was 17 (IQR, 12-22). Median onset-to-puncture time was 230 minutes (IQR, 170-305) and median door-to-puncture time was 87 minutes (IQR, 62-116), with substantial reperfusion in 85.9% (5433/6324) of patients. Adverse events were sICH in 6.7% (449/6693) of patients and in-hospital mortality/hospice discharge in 19.6% (1326/6756) of patients. At discharge, 36.9% (2132/5783) ambulated independently and 23.0% (1225/5334) had functional independence (mRS 0-2). In onset-to-puncture adjusted analysis, time-outcome relationships were nonlinear with steeper slopes between 30 to 270 minutes than 271 to 480 minutes. In the 30- to 270-minute time frame, faster onset to puncture in 15-minute increments was associated with higher likelihood of achieving independent ambulation at discharge (absolute increase, 1.14% [95% CI, 0.75%-1.53%]), lower in-hospital mortality/hospice discharge (absolute decrease, -0.77% [95% CI, -1.07% to -0.47%]), and lower risk of sICH (absolute decrease, -0.22% [95% CI, -0.40% to -0.03%]). Faster door-to-puncture times were similarly associated with improved outcomes, including in the 30- to 120-minute window, higher likelihood of achieving discharge to home (absolute increase, 2.13% [95% CI, 0.81%-3.44%]) and lower in-hospital mortality/hospice discharge (absolute decrease, -1.48% [95% CI, -2.60% to -0.36%]) for each 15-minute increment.
CONCLUSIONS AND RELEVANCE: Among patients with AIS due to large vessel occlusion treated in routine clinical practice, shorter time to endovascular-reperfusion therapy was significantly associated with better outcomes. These findings support efforts to reduce time to hospital and endovascular treatment in patients with stroke.
参考来源
- Jahan R, Saver JL, Schwamm LH, et al. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. JAMA. 2019. PMID: 31310296. doi:10.1001/jama.2019.8286
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。